Gadgets
EXPERT PANEL TO OVERSEE COVID VACCINE
An expert panel to oversee all aspects of its Covid-19 vaccine plan is likely to be led by Niti Aayog’s Dr VK Paul and co-chaired by health secretary Rajesh Bhushan. It will pick the vaccine or vaccines that India can use, plan the finances for what is sure to be an expensive purchase running into billions of dollars, and prioritise the sequence of administration.
In the absence of a vaccine or a cure, the only way to slow the spread of Covid-19 has been wearing masks, social distancing, and restricting regular activities — things that have taken a toll on life and work.
The high-level panel, formed by the cabinet secretary on Friday, includes AIIMS director Dr Randeep Guleria, representatives of the ministries of external affairs, biotechnology, information technology, the Director General of Health services, India’s Aids Research Institute, the Indian Council of Medical Research, and also representatives from states.
The panel’s task starts with identifying the vaccine, or vaccines. Countries such as the US and the UK are spreading their risks, striking deals with multiple vaccine makers who are ahead in the race to develop a vaccine.
It will then decide how the vaccines should be procured—whether foreign agencies should be involved or whether state governments will be allowed to procure on their own or if there should be a central procuring system directly under the supervision of the central government.
The group will also draft a financial plan, prepare a budget and discuss how many can be raised for the mammoth exercise of procurement, distribution, and administration. Finally, the panel will prepare a strategy on inventory management, distribution, and administration. Many of these issues have been discussed over the past month across ministries and institutions.
Read Also: FLIGHT DATA RECORDERS RECOVERED. ‘ANGELS’ COME TO RESCUE
The authorities are carefully watching the development of at least nine vaccines, including at least two Chinese ones, and hoping that the Oxford AstraZeneca vaccine, being made in India by the Adar Poonawalla-led Serum Institute of India, works. That, though is a second-generation problem. India first needs to identify a vaccine and procure enough doses of it.
Gadgets
Oppo Reno 15 likely to launch in India soon with upgraded camera and performance features
Oppo is preparing to launch the Reno 15 series in India, focusing on camera improvements, performance stability and a refined design. Here’s what to expect from its pricing and features.
Gadgets
Samsung Galaxy S25 FE India price leak suggests launch similar to S24 FE
Samsung Galaxy S25 FE India price has surfaced online, hinting at a similar launch price as the S24 FE. The phone brings a 6.7-inch AMOLED display, Exynos 2400 chip, triple rear cameras, and a 4,900mAh battery.
Gadgets
iPhone 17 series launched in India: Price starts at Rs 82,900, goes up to Rs 2.29 lakh
Apple has launched the iPhone 17 series in India with prices starting at Rs 82,900. Pre-booking begins on 12 September, and the phones will be available from 19 September.
Bondi Beach shooting during Jewish festival leaves at least 15 dead
Chaos mars Lionel Messi’s Kolkata GOAT Tour event as fans protest poor arrangements
Delhi enforces new law to regulate fees in private schools
Delhi air quality nears severe as smog blankets city, airport issues advisory
US lawmakers move resolution to roll back Trump’s 50% tariffs on Indian imports
Afghan Men Try To Hang With The Jet Engine Of The Aircraft in Kabul- Afghanistan News – Kabul News
Trending Top 10 News: 10000 Crore Fine on Flipkart, Apple to Launch Unique Feature, Hdfc Bank Job Ad
Trending Top 10 News: Nokia 6310, Apple sales, Bachpan ka Pyar Video Kid, Dainik Bhaskar IT Raid
Trending Top 10 News: Canada bans Indian flights, Rain in Delhi NCR, AIMIM Twitter hacked, Raj Kundra case
